TNFAIP3 and B-cell non-Hodgkin lymphoma: Epigenetic modifications such as histone acetylation or promoter methylation, might further contribute to reduced A20 expression or induction, as has been shown in peripheral blood monocytes in systemic lupus erythematosus (SLE) [33] and B cell lymphoma [34].